Skip to main content

Factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia: a case-control study



The early stage of embryo development is extremely vulnerable to various teratogenic factors, leading to congenital anomalies. In Ethiopia, a significant number of babies are born with congenital anomalies, but the risk factors for the anomalies have never been studied. Understanding the specific risk factors for congenital anomalies is very essential to provide health education that aims at creating awareness and establishing preventive strategic plan/s. The main objective of this study was to assess the risk factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia.


A case-control study was conducted from January 1- June 30, 2015. The participants were recruited at the purposively selected hospitals in Addis Ababa and the Amhara Region. A total of 207 cases and 207 controls were included in the study. Cases were neonates, infants, and children 0-11 months of age with external and internal major congenital anomalies diagnosed by pediatricians. Controls were neonates, infants, and children 0-11 months of age without external and internal anomalies. Data on sociodemographic characteristics, exposure to risk factors, and reproductive history were collected by face to face interviews with children’s mothers/caregivers using a structured questionnaire. Binary logistic regression was employed to explore risk factors associated with the occurrence of the problems.


About 87.4% of the children were below 6 months, and 12.6% were between 6 and 11 months. The majority (59.9%) of the children were male, with the M: F sex ratio of 1.49. The mean age of the mothers was 26 years (16-45 years). Unidentified medication use during early pregnancy (AOR = 4.595; 95% CI: 1.868-11.301, P-value = 0.001), maternal alcohol drinking (AOR = 2.394; 95% CI: 1.212-4.726, P-value = 0.012), and exposure to chemicals (AOR = 9.964; 95% CI = 1.238-80.193, P-value = 0.031) were significantly associated with the occurrence of congenital anomalies. Iron folate use (AOR = 0.051; 95% CI: 0.010-0.260, P-value = < 0.001) before and during early pregnancy had a protective effect on congenital anomaly.


Unidentified medication use, alcohol drinking during early pregnancy, and exposure to chemicals had a significant association with the occurrence of congenital anomalies, whereas iron folate use before and during early pregnancy had a protective effect from congenital anomalies.

Peer Review reports


The early stages of embryo development are a critical period which may mark vulnerability to disruption by teratogenic agents that lead to congenital anomaly [1,2,3]. Congenital anomaly (CA) is defined as a structural or functional defect that may be detected during pregnancy or be visible at birth or later in life. CAs are the major cause of new born/infant morbidity, mortality, and disability in addition to adding to the burden of the health care system [4]. It is estimated that about 20–30% of infant deaths occur due to CAs [5]; severe CAs occur in 3% of live [6, 7], and 20% of still births [8], and 7.9 million children are born with serious CAs, accounting for 6% of all births globally [9].

According to literature, genetic and environmental factors play a major role in causing CAs during the first trimester [10]. Approximately, 7.6 million children are born with CAs worldwide due to genetic factors [11]. Although there is a better understanding of the etiology of CA in the literature, the causes of most of the CAs are still unknown. However, they are believed to be caused by several etiologic factors [12, 13].

The occurrence of certain risk factors, such as maternal chronic diseases, like diabetes, family history, and viral infections during early pregnancy increase the risk of having a baby with CAs [14,15,16,17]. Furthermore, risk factors linked to the occurrence of CAs include unidentified medication/illicit/prescribed drug/s use, alcohol consumption, smoking cigarettes, exposure to radiation, chemical agents, parental age, parental occupation, nutritional deficiencies, and chromosomal mutations as well as socio-economic factors [7, 14, 15, 18,19,20]. Hence, exposure to all of these factors can influence the organogenesis processes of the embryo [7, 12].

Moreover, some studies showed that maternal use of folic acid and multivitamins containing folic acid around conception and the first 3 months of pregnancy have a protective effect against certain types of CAs [21, 22].

In general, the prevalence of CAs varies with race, ethnicity, and geographical regions across the world [7, 11, 16, 23, 24]. In Ethiopia, a significant number of babies are born with CAs, but the causes of these CAs have never been studied. In fact, whether the causes are environmental or genetic factors or interactions between environmental and genetic factors are not known. In addition, there are no preventive strategic plans to reduce or control the occurrence of these problems. It is obvious that children born with major CA are prone to die or even if they survive, they may confront a long-term morbidity and disability and may also undergo repeated surgical interventions. Evidence based information about specific risk factors for CAs are very essential to provide health education to communities, especially to females in the reproductive age. This could not only help to create awareness so as to reduce the occurrence of anomalies but also assists policy makers/responsible bodies to develop preventive strategic plans.

The main objective of this study was to assess the risk factors for CAs in Addis Ababa and the Amhara Region. The results are believed to provide information for public health actions and to create awareness about CAs and their etiologic factors. They may also be used as baseline for further investigations.


Study sites

The study was carried out in Addis Ababa and the Amhara region, Ethiopia.

Addis Ababa, the capital of Ethiopia, has 10 sub-cities with an estimated total population of 3,273,001(47.4% male, 52.6% female). The population of Addis is diverse by ethnicity. The majority of the people are Christians, followed by Muslims and some followers of other religions [25]. The city is subject to population increase through continuous migrations [25]. All of the hospitals in the city provide inpatient, outpatient, and delivery services, except Cure Ethiopia International Children’s Hospital, which does not provide delivery services.

The Amhara Region, the second largest northwest region of the country has a population of 20,399,004 (50.1% male, 49.9% female). The majority of the people live in rural areas and the minority in large and small towns. Most of the Amhara people are Christians, with a good number of Muslims and some followers of other faiths [25]. All of the hospitals in the regional state provide various inpatient and outpatient services including delivery.

Selection of study hospitals

Five public hospitals in Addis Ababa and three in the Amhara Region were purposively selected for this study on the basis of case load. All of the hospitals are referral with high patient flow and various specialized departments or units, which provide various services to neonates, infants, children, and adults.

Study design and sample size

A case-control design was used to investigate exposure status to risk factors for CAs in the case and control children.

A sample of 414 children (207 cases, 207 controls) was recruited for this study. The sample size was calculated by using a ratio of 1:1, power of 90%, a 5% significance level and 38.81% of likelihood of an event in controls (i.e. exposure in controls) [17], and assuming the Odds ratio to be 2. The study children were matched by age. Cases were neonates, infants, and children 0-11 months of age with external and internal major CAs. Major CAs are defined as anomalies that have partial or complete organ/organ system absence/defects, resulting in functional, health, and cosmetic effects, which require surgical repair and rehabilitations [4]. The cases were selected from live births at the study hospitals, neonate units and under five clinics. The type of CAs were classified as major by using WHO/CDC/ICBDSR manual 2014 [4]. Based on WHO/CDC/ICBDSR classification method, the cases with neural tube, orofacial region, musculoskeletal system and genitourinary system defects and less than 12 months of age were purposively selected and included in the study. Children aged 12 months and above and had major and minor CA were excluded. All cases had isolated CAs except one child who had multiple anomalies. The diagnoses of the cases were confirmed through physical examinations and echocardiography (i.e. for cases with heart defects) by pediatricians. The cases were selected purposively. The controls were neonates, infants, and children 0-11 months of age without external and internal CAs. The controls were randomly selected in the same hospitals where children with CAs were identified. All children aged 0-11 months constituted the source population.

Data collection method

The data were collected by a face to face interview of the children’s mothers/caregivers by using a structured questionnaire and checklists. The questionnaire prepared in English and translated to Amharic was pretested at other hospitals and amended according to the results. Data were collected on residence, sociodemographic characteristics, reproductive/pregnancy history and adverse outcomes, family history of CAs, socio-economic status, parental ethnicity, parental occupation, maternal educational level, maternal nutritional status/history, parental exposures to risk factors and/or teratogenic agents, such as radiation, chemicals, pesticides, etc. for CAs, maternal illness/disease, medication/illicit drug use, substance abuse (alcohol consumption, smoking), blood relationships among parents, antenatal care visits, folic acid and multivitamin use, and birth order of children. The data were gathered at delivery rooms/wards, neonatal units, and under five clinics. Prior to data collection, data collectors (nurses, midwifes) were trained for 2 days. The data were collected from January 1- June 30, 2015.

Data management and analysis

Data were checked on daily basis by collectors and further overseen by the principal investigator and supervisors for completeness and correctness during collection periods. It was also rechecked during data entry. The data were coded and entered into Epi-Info version 3.5.1 and then transferred to SPSS version 21 for analysis. Data cleaning, error checking, and analysis were conducted by using SPSS version 21. Data were calculated by using frequency, cross tabulation, and binary logistic regression. Significance level was considered at less than 0.05 p-value. Crude Odds ratio and confidence level were calculated. After the crude Odds ratios were identified, adjusted Odds ratios were computed to assess risk factors associated with the occurrence of CAs by using backward stepwise logistic regression. Exposure variables with P-value ≤0.2 in the crude Odds ratio were entered into the multivariable logistic regression model to observe their relationships and CAs (i.e. to observe associated variables with CAs in the adjusted Odds ratio). The characteristics of cases and controls were explained in percentages and numbers. The crude and adjusted Odds ratios, confidence intervals, p-values and the overall findings are presented in the result section in the form of texts and tables.

Ethical clearance

Ethical clearance was obtained from Addis Ababa University, College of Health Sciences Institutional Review Board, the National Research Ethics Review Committee, Addis Ababa City Administration Health Bureau Ethical Clearance Committee, and the Amhara National Regional State Health Bureau Regional Health Research Laboratory Center. Supportive letters were written to all zonal health departments and study hospitals by the health bureaus. Ethical and supportive letters were submitted to all hospital administrators. The purpose of the study was explained to the participant children’s mothers/caregivers. Data collection began after permissions were obtained from hospital managers/medical directors and after a written consent was obtained from children’s mothers/caretakers. Data collected from the participants were kept in secured and locked cabinets in order to maintain confidentiality.


Socio-demographic characteristics of the study participants

The sample consisted of 414 (207 cases, 207 controls) children. The age of children ranged from 1 day to 11 months. About 87.4% of the children were below 6 months and 12.6% between 6 and 11 months. The majority (59.9%) of the children were male and 40.1% female with a sex ratio of 1.49, respectively. The mean age of the children’s mothers was 26 years (range 16-45). Among the participants, 63.3% were urban and 36.7% rural dwellers. In terms of income, 47.8% had middle and 37.2% low economic status as stated by the mothers/respondents. The majority (93.5%) of the children’s mothers were married; about 37.4% had no formal education; 31.9% had primary education, and 30.7% secondary and higher level of education. By religious affiliation, 72.2, 27.3, and 0.5% of the parents were Christian, Muslim, and others, respectively. Among the mothers, 53% were housewives, 17.9% government, private, or self-employed, 14.3% farmers, and 14% jobless. Similarly, 49.3, 38.9, and 11.8% of the children’s fathers were employees, farmers, and jobless, respectively. The major (62.1%) ethnic group in this study were Amhara, 23.2% Oromo, 5.6% Guragie, 3.6% Tigre, and 3.6% Seltie. The other socio-demographic characteristics of the participants are shown in Table 1.

Table 1 The socio-demographic characteristics of the study participants, Addis Ababa and the Amhara Region, Ethiopia, 2016

About 12 (5.8%) and 13 (6.3%) of mothers whose children had and had no CAs, respectively, were in the 15-19 years of age group. Besides, 49 (23%) and 68 (32.9%) of mothers whose children were exposed and not exposed to CAs, respectively, were 20-24 years of age. Similarly, 69 (33.3%) and 68 (32.9%) of the mothers who had children with and without CAs, respectively, were in the 25–29 years of age group, whereas 49 (23.7%) and 31 (15%) mothers who had and free children, respectively, were in the 30–34 years of age group. Likewise, 28 (13.5%) and 27 (13%) of the mothers who had affected and non-affected children, respectively, were 35–39 years of age.

About 99.5% of the CAs identified were isolated/single, while 1 (0.5%) was multiple. The frequency of CAs by organ/organ system is shown in Table 2.

Table 2 Frequency of congenital anomalies by organ/organ system among the study subjects, Addis Ababa and the Amhara Region, Ethiopia, 2016

Reproductive, obstetric, and offspring background/history

As far as the birth order of children was concerned, 32.9, 19.8, and 47.3% were first, second, third and above (3+) children to their families, respectively. Among the controls, about 48.3, 22.7, and 29% were first, second, third and above (3+) children, respectively, to their parents. About 16.4% of mothers whose children had CAs and 9.2% of the mothers who had children without CAs, had no antenatal care (ANC) visits. The total number of pregnancy history, preterm, miscarriage, stillbirth, gravidity, gestational age at first ANC, number of live births, and neonate/infant/child deaths are presented in Table 3.

Table 3 Reproductive history of the study participants/children’s mothers, Addis Ababa and the Amhara Region, Ethiopia, 2016

Risk factors associated with congenital anomalies

There were maternal/medical illnesses (i.e. infections or chronic diseases such as diseases with fever, chronic disorders) in 24 (11.6%) of the mothers who had children with CAs and 13 (6.3%) of mothers whose children were not affected with CAs. Passive smokers were observed in 37 (17.9%) and 28 (13.5%) of mothers who had children with and without CAs, respectively. Among the participants, unidentified medication use in early pregnancy by mothers whose children had and had no CAs were 16.9 and 3.9%, respectively. Contraceptive (both pill and injection) use around conception was 11.6% in the mothers who had children with CAs and 2.4% in the mothers who had no children with CAs. In addition, anemia was observed in 55 (26.6%) of the affected children’s mothers and 37 (17.9%) of mothers whose children had no CAs (Table 4).

Table 4 Participant’s response on risk factors for congenital anomaly: Results from multivariable analysis-adjusted for substance abuse/behavioral, parental, and environmental factors, maternal illness, iron folate/folic acid, multivitamin, and vegetable use variables, Addis Ababa and the Amhara Region, Ethiopia, 2016

Blood relationships among parents were reported in 4.8% of children’s the exposed mothers and 1.0% of not exposed children’s mothers. Family history of CA as seen in the children was also reported in 4.3% of the affected children’s parents and 1.4% of the parents whose children had no CAs. Exposure to chemicals among mothers who had children with and without CAs was 6.3 and 0.5%, respectively. On the other hand, two (0.97%) of mothers whose children had CAs used fertility enhancing drugs. Again, one (0.5%) of the affected child mother had diabetes during pregnancy. On the contrary, mothers who had children without CAs reported no use of fertility enhancing drugs around conception and had no diabetes during and before pregnancy. In addition, none of the affected children’s mothers took multivitamins before they got pregnant, while one (0.5%) of the mother who had child without CA used multivitamin before pregnancy. Moreover, about 25 (12.1%) of mothers whose children had CAs and 17 (8.2%) of the mothers who had children without CAs, had no food shortage before and during pregnancy (Table 4). However, the above-mentioned factors were not statistically significant in the multivariable analysis, the adjusted Odds Ratio. In addition, maternal age, parental ethnicity, mothers educational level, parental occupation (Table 1) and parity, birth order, preterm, still birth, and miscarriage (Table 3) were not statistically significant in the crude and adjusted Odds Ratio analysis.

Thirteen variables were entered into the COR analysis. Of these, unidentified medication used during the first 3 months of gestation (COR = 5.062; 95% CI: 2.286-11.206, P-value = < 0.001), alcohol consumption during early/throughout pregnancy (COR = 3.256; 95% CI: 1.823-5.816, P-value = < 0.001), anemia during early pregnancy (COR = 1.663; 95% CI: 1.038-2.662, p-value = 0.034), contraceptive use around conception (COR = 5.298; 95% CI: 1.980- 14.175, P-value = 0.001), and chemical exposure during early pregnancy (COR = 13.804; 95% CI; 1.789-106.522, P-value = 0.012), and blood relation among parents (COR = 5.203; 95% CI:1.126-24.046, P-value = 0.035) were associated with CAs in the crude Odds ratio analysis. On the other hand, folic acid/iron folate (COR = 0.082; 95% CI: 0.019-.354, P-value = 0.001) and vegetable servings/use during early pregnancy (COR = 0.536; 95% CI: 0.344-0.835, P-value = 0.006) was protective against the occurrence of CAs (Table 4). However, vegetable serving was not associated with the occurrence of CAs in the adjusted Odds ratio analysis.

Twelve variables (alcohol drinking, anemia, iron folate/folic acid, unidentified medication, contraceptive, exposure to chemicals, vegetable serving, blood relationship between child parents, exposure to radiation, maternal illness, family history, and food shortage during early pregnancy) whose value ended up with 0.2 and below in the crude Odds ratio were entered into the multivariable logistic regression model to observe exposure variables associated with CAs. As indicated in Table 4, unidentified medication use (AOR = 4.595; 95% CI: 1868-11.301, P-value = 0.001), maternal alcohol drinking in early pregnancy (AOR = 2.394; 95% CI: 1.212-4.726, P-value = 0.012), and exposure to chemicals during early pregnancy (AOR = 9.964; 95% CI: 1.238-80.193, P-value = 0.031) were significantly associated with the occurrence of CAs. On the contrary, iron folate/folic acid supplementation (use) before and during early pregnancy (AOR = 0.051; 95% CI: 0.010-0.260, P-value = < 0.001) had a protective effect against CA.


According to our findings, unidentified medication use, alcohol consumption during early pregnancy or throughout pregnancy, and exposure to chemicals during early pregnancy had significant associations with the occurrence of CAs in this study, whereas iron folate supplementation before and during early pregnancy showed a protective effect against CA.

Like our study, scientific literature reports that drug usage during pregnancy is associated with CAs [26,27,28,29,30,31]. In Ethiopia, drugs are being sold by private drug venders, stores, clinics, and some shops with and without prescriptions. This indicates that mothers are likely to use medications/over-the counter drugs during their early pregnancy. Therefore, responsible bodies should control over-the-counter.

The association of alcohol drinking during and before early pregnancy and CA was also reported by Grewal et al., [32], Zhang et al., [33], and O’Leary et al., [34, 35]. In the liver, alcohol is metabolized into acetaldehyde, a toxic chemical/substance. To convert this toxic substance into a non-toxic and usable chemical, enzyme acetaldehyde dehydrogenases that secreted converts the acetaldehyde into acetic acid, which is useable by the body. However, when the unconverted acetaldehyde accumulates in the body, it causes irritation of the cells and tissues and then damages the cells and tissues, leading to metabolism and cellular growth abnormalities [36]. Moreover, alcohol is capable of crossing the placenta membrane and being carried to all developing cells and tissues of the embryo and fetus, and as a result causes damages to the developing tissues and cells and subsequently leads to a structural abnormality. Furthermore, alcohol drinking during pregnancy results in a serious consequences which manifest with recognized characteristics of physical and mental abnormal features after a baby is born [36,37,38,39,40,41,42,43,44].

In Ethiopia, alcohol is consumed by the community [45, 46], particularly locally made alcoholic beverages known as “areki” and “tella” in Amharic are consumed by both men and women in rural communities, especially among Christians, more specifically Orthodox Christians, across the country, whereas some urban dwellers, including women drink beer and other alcoholic drinks. In this study, women who consumed alcohol daily and women who took alcohol to an increasing degree had children with CAs. Therefore, health education is essential for the community, particularly women in the 15-49 years of age group.

In the present study, exposure to chemicals had a significant association with CAs. Likewise, exposure to chemicals has been reported as having a significant association with the occurrence of CAs [47,48,49,50,51].

In this study, mothers of cases who reported maternal/medical illnesses during early pregnancy had higher odds of babies with CAs compared to mothers of controls. Similarly, maternal diseases or medical illnesses, such as syphilis, Rubella, measles, other viral infections, [52,53,54,55,56] and chronic diseases were reported by several researchers as known causes of CAs [14, 18, 52,53,54,55,56,57,58,59].

Many studies reported that iron folate/folic acid supplementation in the early pregnancy and before protected or reduced the occurrence of certain CAs. For example, neural defects can be reduced if a pregnant woman appropriately takes the recommended dose of iron folate/folic acid. Women who take iron folate/folic acid are less likely to have babies with CA compared to those who do not take folic acid during and before early pregnancy [14, 60,61,62,63,64,65,66,67,68]. Folic acid together with vitamin B12 plays a vital role in the synthesis of nucleic acid, lipids, and proteins, required for cell division. Iron folate/folic acid also has a role in amino acids metabolisms that are needed for DNA and RNA synthesis and plays an important role as an antioxidant agent. Therefore, it is essential to make it available to all pregnant women.

Various studies suggested that multivitamin or folic acid containing multivitamin use during/ before pregnancy reduces/protects against some CAs [60, 65,66,67,68]. Multivitamins are essential organic substances, which are required by the body for normal body metabolic functions, body building, and controlling chemical reactions, such as converting food substances into energy and living tissues, as well as for survival or living healthy. Some components of multivitamins act as antioxidant substances (i.e. protect cells from damage by free radicals), for example, vitamin “E” and “C”. Moreover, some components of multivitamins are also important for body defense mechanisms, for instance, zinc, vitamin “C”, and vitamin “A” protect the body from diseases.

As observed in this study, in Ethiopia, health care providers might not have been providing folic acid or multivitamin containing folic acid supplementation to pregnant women until recent times. However, recently the Federal Ministry of Health recommended iron folate supplementation to all pregnant women although most such women have not been provided still. Moreover, research on folic acid supplementation and knowledge of women about folic acid use during pregnancy is limited in Ethiopia.

In this study, maternal age, ethnicity, sex of child, maternal education, and parity were not significantly associated with the occurrence of CAs. This finding is in agreement with that of a study conducted in Saudi Arabia by Salih et al., [18]. However, previous studies have shown a linkage to maternal age, (greater than 35) [14, 69], maternal education, and parity with the occurrence of CA [69].

In the present study, cigarette smoking and passive smoking were not associated with CAs although several researchers reported that smoking/passive smoking was associated with a specific types of CAs [32, 70,71,72,73]. In some societies, women in the reproductive age group smoke cigarettes. This may be due to cultural and personal habits. In addition, exposure to radiation had no statistically significant link in this study. Moreover, blood relationship, family history, and the Odds of having children with CA had no statistically significant associations in this study. To the contrary, other studies reported that a significant association occurred between blood relationship/family history and CA [18, 73,74,75]. This variation might be due to differences in the cultures of consanguinity marriage and genetic makeup. In addition, there were no associations between birth order, preterm, miscarriage, and CAs in the present study.

In general, the present study indicates that the characteristics of cases and controls are closer, except for a few variations, like maternal alcohol drinking and maternal illness. In addition, our findings are in line with some previous reports and at variance with others. The reason they are different from the reports of some studies may be differences in socio-demographic, geographic, study setting, methodological, and environmental characteristics.


The findings of this study showed that alcohol drinking, unidentified medication use, and exposure to chemicals had significant associations with the occurrence of CAs. Iron folate use before and during pregnancy indicated a protective effect on CAs. However, current iron folate and multivitamin supplementation to pregnant women has been inadequate and infrequent because only very few women are observed using them during pregnancy, while the majority of women in the reproductive age groups are not getting prior to conception and during early pregnancy. Therefore, we emphasize that the supplementation is required to reproductive age groups, particularly around conception and during early pregnancy.

Although the causes of CAs are unknown and not studied in Ethiopia, screening nutritional deficiencies, chronic diseases, such as anemia, diabetics, infections/diseases (i.e. viral infections and sexually transmitted diseases) and establishing preventive measures, for example, health education to the public, specifically to reproductive age women are very important. So, to understand and identify the risk factors for CAs, it is necessary to conduct further population based investigations in different parts of the country to further ascertain the presently observed risk factors in association with CAs, as well as fully explore factors, which are not associated with CAs.



Antenatal care


Congenital anomaly


Congenital anomalies


World Health Organization/Centers for Disease Control and Prevention/International clearinghouse for Birth Defects Surveillance and Research


  1. 1.

    Francine R, Psascale S, Aline H. Congenital anomalies: prevalence and risk factors. Universal J Public Health. 2014;2(2):58–63.

    Google Scholar 

  2. 2.

    Yamada S, Nakashima T, Hirose A, Yoneyama A, Takeda T, Takakuwa T. In: Yamada S, editor. Developmental anatomy of the human embryo – 3D-imaging and analytical techniques, the human embryo; 2012. ISBN: 978-953-51-0124-6, InTech, Available from:

    Google Scholar 

  3. 3.

    Taye M, Afework M, Fantaye W, Diro E, Worku A. Magnitude of birth defects in central and Northwest Ethiopia from 2010-2014: a descriptive retrospective study. PLoS One. 2016;11(10):e0161998.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    World Health Organization/US-Center for Disease Control and Prevention/International Clearance House on Birth Defects Surveillance and Research. Birth defects surveillance: a manual for programme managers. Geneva: World Health Organization; 2014.

    Google Scholar 

  5. 5.

    Ahmed AM, el Kader SA, El Hamid A, Gaafar M. Assessment of risk factors for fetal congenital anomalies among pregnant women at Cairo University hospitals. J Am Sci. 2011;7(12):899–907.

    Google Scholar 

  6. 6.

    Mohammed AR, Mohammed SA-R, AbdulFetah AMH. Congenital anomalies among children: knowledge and attitude of Egyptian and Saudi mothers. J Biol Agric Healthc. 2013;3(20):18–29.

    Google Scholar 

  7. 7.

    Brent RL. Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. J Am Acad Pediatr. 2004;113(4):957–68.

    Google Scholar 

  8. 8.

    Serra-Juhe C, Rodriguez-Santiago B, Cusco I, Vendrell T, Camats N, Toran N, Perez-Jurado LA. Contribution of rare copy number variants to isolated human malformations. PLoS One. 2012;7(10):1–8.

    Article  Google Scholar 

  9. 9.

    Çanaku D, Toçi E, Roshi E, Burazeri G. Prevalence and factors associated with congenital malformations in Tirana Albania during 2011-201. Mater Sociomed. 2014;26(3):158–62.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Sun G, Xu ZM, Liang JF, Li L, Tang DX. Twelve-year prevalence of common neonatal congenital malformations in Zhejiang Province, China. World J Pediatr. 2011;7(4):331–6.

    Article  PubMed  Google Scholar 

  11. 11.

    Kaur A, Singh JR. Chromosomal abnormalities: genetic disease burden in India. Int J Hum Genet. 2010;10(1-3):1–14.

    Article  Google Scholar 

  12. 12.

    Butt F, Shahzad R, Pasha I. Pattern and outcome of congenital anomalies and maternal risk factor association. Biomedica. 2013;29:234–9.

    Google Scholar 

  13. 13.

    Basso O, Olsen J, Christensen K. Recurrence risk of congenital anomalies-the impact of paternal, social, and environmental factors: a population-based study in Denmark. Am J Epidemiol. 1999;150(6):598–604.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Kishimba RS, Mpembeni R, Mghamba J. Factors associated with major structural birth defects among newborns delivered at Muhimbili National Hospital and municipal hospitals in Dar Es Salaam, Tanzania 2011-2012. Pan Afr Med J. 2015;20:153. Available online at:

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    The McGraw-Hill Company. Congenital malformations. In: Kumar P, Burton B, editors. Evidence base evaluation and management. USA; 2008.

  16. 16.

    Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage1–3. Am J Clin Nutr. 2005;81(Supp. 1):1213S–12137S.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, et al. Maternal smoking and congenital heart defects. Pediatrics. 2008;121(4):E810–6.

    Article  PubMed  Google Scholar 

  18. 18.

    Salih MAM, Murshid WR, Mohamed AG, Ignacio LC, de Jesus JE, Baabbad R, HME B. Risk factors for neural tube defects in Riyadh City, Saudi Arabia: case-control study. Sudan J Paediatr. 2014;14(2):49–60.

    PubMed  PubMed Central  Google Scholar 

  19. 19.

    Grandi DC, Maccarone MB, Luchtenberg G, Rittler YM. La obesidad materna como factor de riesgo para defectos congenitos. Rev Hosp Mat Inf Ramon Sarda. 2012;31(3):100–2.

    Google Scholar 

  20. 20.

    Desrosiers TA, Herring AH, Shapira SK, Hooiveld M, Luben TJ, Herdt-Losavio ML, et al. Paternal occupation and birth defects: findings from the national birth defects prevention study. Occup Environ Med. 2013;69(8):534–42.

    Article  Google Scholar 

  21. 21.

    Rozendaal AM, van Essen AJ, te Meerman GJ, Bakker MK, van der Biezen JJ, Goorhuis-Brouwer SM, et al. Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study. Eur J Epidemiol. 2013;

  22. 22.

    Mobasheri E, Keshtkar A, Golalipour MJ. Maternal folate and vitamin B12 status and neural tube defects in northern Iran: a case control study. Iran J Pediatr. 2010;20(2):167–73.

    PubMed  PubMed Central  Google Scholar 

  23. 23.

    World Health Organization Regional Office for South-East Asia. Workshop on birth defects surveillance. Colombo; 2012. p. 10–3.

  24. 24.

    Prajapati V, Kacha AR, Kakkad KM, Damor PB, Nandaniya AM. Study of congenital malformation in neonates born at tertiary care hospital. National J Community Med. 2015;6(1):30–4.

    Google Scholar 

  25. 25.

    Central Statistical Agency [Ethiopia]. Statistical abstracts: population projection of Ethiopia for all regions at wereda levels, from 2014-2017. Addis Ababa; 2013.

  26. 26.

    van Gelder MMHJ, Bos JHJ, Roeleveld N, de Jon-van den Berg LTW. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009. Hum Reprod. 2013;0(0):1–7.

    Google Scholar 

  27. 27.

    van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N. Teratogenic mechanisms of medical drugs. Hum Reprod Update. 2010;16(4):378–94.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Mohammed MA, Ahmed JH, Workicho A, Aljadhey HS. Medications use among pregnant women in Ethiopia: a cross sectional study. J Appl Pharm Sci. 2013;3(04):116–23. Available online at

    Google Scholar 

  29. 29.

    Admasie C, Wasie B, Abeje G. Determinants of prescribed drug use among pregnant women in Bahir Dar city administration, Northwest Ethiopia: a cross sectional study. BMC Pregnancy Childbirth. 2014;14:325.

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Abeje G, Admasie C, Wasie B. Factors associated with self-medication practice among pregnant mothers attending antenatal care at governmental health centers in Bahir Dar city administration, Northwest Ethiopia, a cross sectional study. Pan Afr Med J. 2015;20:276. Available online at:

    Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Kebede B, Gedif T, Getachew A. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia. Pharmacoepidemiol Drug Saf. 2009;18:462–8.

    Article  PubMed  Google Scholar 

  32. 32.

    Grewal J, Carmichael SL, Ma C, Lammer EJ, Shaw GM. Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A. 2008;82:519–26.

    CAS  Article  Google Scholar 

  33. 33.

    Zhang X, Li S, Wu S, Hao X, Guo S, Suzuki K, et al. Prevalence of birth defects and risk-factor analysis from a population-based survey in Inner Mongolia, China. BMC Pediatr. 2012;12:125.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    O'Leary CM, Elliott EJ, Nassar N, Bower C. Exploring the potential to use data linkage for investigating the relationship between birth defects and prenatal alcohol exposure. Birth Defects Res A. 2013;97:497–504.

    Article  Google Scholar 

  35. 35.

    O'Leary CM, Nassar N, Kurinczuk JJ, de Klerk N, Geelhoed E, Elliott EJ, Bower C. Prenatal alcohol exposure and risk of birth defects. Pediatrics. 2010;126(4):e843–50.

    Article  PubMed  Google Scholar 

  36. 36.

    Yeigh T, Kean B. Drinking and congenital birth defects: alcohol awareness in the northern rivers region of new South Wales, Australia. Int Electron J Health Educ. 2005;8:153–66.

    Google Scholar 

  37. 37.

    Assadi F. Effects of prenatal alcohol exposure on the developing kidneys. Iran J Pediatr. 2008;18(1):5–10.

    Google Scholar 

  38. 38.

    Spagnolo A. Teratogenesis of alcohol. Ann 1st Super Sanita. 1993;29(1):89–96.

    CAS  Google Scholar 

  39. 39.

    Ministry for Children and Families Edition. Parenting children affected by fetal alcohol syndrome. A guide for daily living. Ministry for children and families edition (British Columbia). Canada: Published by the society of special needs adoptive parents in cooperation with the B.C. Ministry for Children and Families Child Protection Division; 1999.

    Google Scholar 

  40. 40.

    de Sanctis L, Memo L, Pichini S, Tarani L, Vagnarelli F. Fetal alcohol syndrome: new perspectives for an ancient and underestimated problem. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies. Int Soc Perinat Obstet. 2011;24(Suppl 1):34–7.

    CAS  Google Scholar 

  41. 41.

    Ornoy A, Ergaz Z. Alcohol abuse in pregnant women: effects on the fetus and newborn, mode of action and maternal treatment. Int J Environ Res Public Health. 2010;7(2):364–79.

    Article  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. Dev Behav Pediatr. 2004;25(4):228–38.

    Article  Google Scholar 

  43. 43.

    Werk CM, Cui X, Tough S. Fetal alcohol spectrum disorder among aboriginal children under six years of age and living off reserve: first nations Child & Family Caring Society of Canada. First Peoples Child Fam Rev. 2013;8(1):7–13.

    Google Scholar 

  44. 44.

    Maier SE, West JR. Drinking patterns and alcohol-related birth defects. Alcohol Res Health. 2001;25(3):168–74.

    CAS  PubMed  Google Scholar 

  45. 45.

    Anteab K, Demtsu B, Megra M. Assessment of prevalence and associated factors of alcohol use during pregnancy among the dwellers of Bahir-Dar City, Northwest Ethiopia. Int J Pharma Sci Res. 2014;5(12):939–45. ISSN: 0975-9492

    Google Scholar 

  46. 46.

    Central Statistical Agency [Ethiopia] and ICF International. Ethiopia demographic and health survey 2011. Addis Ababa and Calverton: Central Statistical Agency and ICF International; 2012.

    Google Scholar 

  47. 47.

    Mitro SD, Johnson T, Zota AR. Cumulative chemical exposures during pregnancy and early development. Curr Environ Health Rep. 2015;2(4):367–78.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Bell E, Hertz-Picciotto I, Beaumont J. A case-control study of pesticides and fetal death due to congenital anomalies. Epidemiology. 2001;12(2):148–56.

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Araneta MRG, Schlangen KM, Edmonds LD, Destiche DA, Merz RD, Hobbs CA, et al. Prevalence of birth defects among infants of gulf war veterans in Arkansas, Arizona, California, Georgia, Hawaii, and Iowa, 1989-1993. Birth Defects Res A. 2003;67:246–60.

    CAS  Article  Google Scholar 

  50. 50.

    Dolk H, Vrijheid M, Armstrong B, Abramsky L, Bianchi F, Garne E, et al. Risk of congenital anomalies near hazardous-waste landfill site in Europe: the EUROHAZCON study. Lancet. 1998;352:423–7.

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Heeren GA, Tyler J, Mandeya A. Agricultural chemical exposures and birth defects in the eastern Cape Province, South Africa a case – control study. Environ Health. 2003;2:11. Available from:

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    WHO fact sheet on rubella: includes key facts, definition, symptoms, congenital rubella syndrome, vaccination, WHO response; 2016. Available at:

  53. 53.

    WHO Fact Sheet. The measles and rubella initiative is a global partnership committed to ensuring no child dies from measles or is born with congenital rubella syndrome, 2016.

    Google Scholar 

  54. 54.

    Centers for Disease Control and Prevention (US-CDC): Congenital syphilis - CDC fact sheet. 2015.

    Google Scholar 

  55. 55.

    Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006:1–12. Available at

  56. 56.

    De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G, Scambia GS. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012:1–4.

  57. 57.

    Li Z, Ren A, Liu J, Pei L, Zhang L, Guo Z, Li Z. Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in northern China. Birth Defects Res A Clin Mol Teratol. 2007;79(4):295–300.

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    Liu S, Joseph KS, Lisonkova S, Rouleau J, Van den Hof M, Sauve R, Kramer MS. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Am Heart Assoc. 2013:1–20.

  59. 59.

    Csaky-Szunyogh M, Vereczkey A, Kosa Z, Gerencser B, Czeizel AE. Risk and protective factors in the origin of conotruncal defects of heart--a population-based case-control study. Am J Med Genet A. 2013;161(10):2444–52.

    CAS  Google Scholar 

  60. 60.

    Fernandez N, Henao-Mejia J, Monterrey P, Perez J, Zarante I. Association between maternal prenatal vitamin use and congenital abnormalities of the genitourinary tract in a developing country. J Pediatr Urol. 2012;8:121–6.

    Article  PubMed  Google Scholar 

  61. 61.

    Chan AC, Essen PV, Scott H, Haan EA, Sage L, Scott J, Gill TK, Nguyen A-MT. Folate awareness and the prevalence of neural tube defects in South Australia, 1966-2007. MJA. 2008;189(10):566–9.

    PubMed  Google Scholar 

  62. 62.

    De Wals P, Tairou F, Allen MIV, Soo-Hong U, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135–42.

    CAS  Article  PubMed  Google Scholar 

  63. 63.

    Bjӧrklund NK, Gordon R. A hypothesis linking low folate intake to neural tube defects due to failure of post-translation methylations of the cytoskeleton. Int J Dev Biol. 2006;50:135–41.

    Article  Google Scholar 

  64. 64.

    Bortolus R, Blom F, Filippini F, van Poppel MN, Leoncini E, de Smit DJ, et al. Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands. BMC Pregnancy Childbirth. 2014;14:166.

    Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Wilson R, Audibert F, Brock J, Carroll J, Cartier L, Gagnon A, et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can. 2015;37(6):534–52.

    Article  PubMed  Google Scholar 

  66. 66.

    Musumeci G, Castrogiovanni P, Trovato F, Parenti R, Szychlinska M, Imbesi R. Pregnancy, embryo-fetal development and nutrition: physiology around fetal programming. J Histol Histopathol. 2015;2(1):1.

    Article  Google Scholar 

  67. 67.

    Munger RG, Sauberlich HE, Corcoran C, Nepomuceno B, Daack-Hirsch S, Solon FS. Maternal vitamin B-6 and folate status and risk of oral cleft birth defects in the Philippines. Birth Defects Res A Clin Mol Teratol. 2004;70(7):464–71.

    CAS  Article  PubMed  Google Scholar 

  68. 68.

    Shaw G, Nelson V, Carmichael S, Lammer E, Finnell R, Rosenquist T. Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology. 2002;13(6):625–30.

    Article  PubMed  Google Scholar 

  69. 69.

    Nili F, Jahangir T. Risk factors for neural tube defects A study at university affiliated hospitals in Tehran. Arch Iranian Med. 2006;9(1):20–5.

  70. 70.

    Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington infant study. Pediatrics. 2011;127(3):e647–53.

    Article  PubMed  Google Scholar 

  71. 71.

    Little J, Arslan MT, Mossey PA. Smoking and orofacial clefts. A United Kingdom–based case-control study. Cleft Palate Craniofac J. 2004;41(4):383–6.

    Article  Google Scholar 

  72. 72.

    Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17(5):589–604.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  73. 73.

    Honein MA, Paulozzi LJ, Moore CA. Family history, maternal smoking, and clubfoot: an indication of a gene-environment interaction. Am J Epidemiol. 2000;152(7):658–64.

    CAS  Article  PubMed  Google Scholar 

  74. 74.

    Raza MZ, Sheikh A, Ahmed SS, Sajid A, Naqvi SMA. Risk factors associated with birth defects at a tertiary care center in Pakistan. Ital J Pediatr. 2012;38(68):1–7.

    Google Scholar 

  75. 75.

    Mosayebi Z, Movahedian AH. Pattern of congenital malformations in consanguineous versus nonconsanguineous marriages in Kashan, Islamic Republic of Iran. La Revue de Sante de la Mediterranee orientale. 2007;13(4):868–74.

    CAS  Google Scholar 

Download references


We would like to thank midwives, nurses, and other health professionals working at Tikur Anbesa General Specialized Hospital, Zewditu Memorial Hospital, Gandhi Memorial Hospital, St. Paul Specialized Millennium Hospital, Yekatit 12 Hospital, Desse Referral Hospital, Felege Hiwet Referral Hospital, and Gondar University Hospital for their support. We would like to appreciate and acknowledge the participants. We wish to thank the medical directors and managers of the respective hospitals for their support and permission. We would also like to thank all those who assisted us in one way or another during data collection. Lastly, we would like to acknowledge Addis Ababa University and the University of Gondar for their special support.


This study obtained fund from Addis Ababa University and the University of Gondar for data collection only. The authors declare that they have not received funds for the publication of this manuscript. The authors also declare that they have had no external source of grant/fund for both data collection and publication.

Availability of data and materials

The dataset supporting the conclusion of this study are available within the manuscript.

Author information




Conceived the idea: MT. Designed the methodology: MT, MA, WF, ED, AW. Conducted the study: MT, MA, WF, ED, AW. Interpreted data: MT, MA, WF, ED, AW. Data analysis: MT, AW. Wrote draft manuscript: MT. Wrote the final manuscript: MT, AW. Review and edit the manuscript: MT, MA, WF, ED, AW. All authors read and approved the final manuscript and agreed for submission: MT, MA, WF, ED, AW.

Corresponding author

Correspondence to Molla Taye.

Ethics declarations

Ethics approval and consent to participate

The study was reviewed and approved by the College of Health Sciences Institutional Review Board, Addis Ababa University, Ref. No. 060/14, dated June 12, 2014; the National Research Ethics Review Committee, Ref. No. 3.10/781/07, dated October 16, 2014; HARI-ALERT Ethical Review Committee, Project Reg. No. PO58/14, dated December 23, 2014; Addis Ababa City Administration Health Bureau Ethical Clearance Committee, Ref. No. A/A/H/B/1972/25, dated 27/10/2014; and the Amhara National Regional State Health bureau Regional Health Research Laboratory Center Ref. No. /20/4963, dated 27/01/2007(Ethiopian Calendar). Data were collected after verbal and written agreements to participate were secured from children’s mothers/caregivers.

Consent for publication

Not applicable.

Competing interests

We declared that we have no financial and nonfinancial competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Taye, M., Afework, M., Fantaye, W. et al. Factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia: a case-control study. BMC Pediatr 18, 142 (2018).

Download citation


  • Congenital anomaly
  • Case-control
  • Teratogen
  • Risk/Associated factors